Press Releases

Company press releases and official corporate announcements.

A centralized feed of corporate press releases, earnings announcements, mergers, and official statements. Content is presented for informational purposes and may require additional analysis for market relevance.

Articles

12,272 total articles

Willis Lease Finance Corporation Acquires Three Airbus A330-300 Aircraft That Will Be Leased to China Airlines and EVA Air

Willis Lease Finance Corporation Acquires Three Airbus A330-300 Aircraft That Will Be Leased to China Airlines and EVA Air

Willis Lease Finance Corporation has acquired three Airbus A330-300 aircraft that will be leased to China Airlines and EVA Air. This strategic purchase aims to capitalize on strong demand for aviation assets amid fleet growth and maintenance capacity constraints, further expanding Willis Lease's portfolio and reinforcing its global aviation service…

OptimizeRx Launches Natural Language Audience Builder for Life Sciences DSPs and Agency Media Planning Platforms

OptimizeRx Launches Natural Language Audience Builder for Life Sciences DSPs and Agency Media Planning Platforms

OptimizeRx Corp. announced the launch of its patent-pending Natural Language Audience Builder (NLAB), an AI-driven tool designed for integration within demand-side platforms (DSPs) and agency media planning platforms. NLAB allows life sciences marketers to build and refine custom healthcare provider audiences using real-world evidence and proprieta…

Plus Therapeutics Secures National Coverage Agreement with Elevance Health for CNSide® Cerebrospinal Fluid Assay for Metastatic CNS Cancer

Plus Therapeutics Secures National Coverage Agreement with Elevance Health for CNSide® Cerebrospinal Fluid Assay for Metastatic CNS Cancer

Plus Therapeutics' subsidiary CNSide Diagnostics has signed a national coverage agreement with Elevance Health to provide the CNSide® Cerebrospinal Fluid Tumor Cell Enumeration assay, expanding coverage to approximately 126 million people in the U.S. The CNSide® assay aids rapid diagnosis and treatment monitoring for patients with leptomeningeal me…

Prairie Operating Co. Appoints Gregory S. Patton Chief Executive Officer and Director and Michael J. Shelly Chief Financial Officer

Prairie Operating Co. Appoints Gregory S. Patton Chief Executive Officer and Director and Michael J. Shelly Chief Financial Officer

Prairie Operating Co., a Nasdaq-listed independent energy company focused on oil and natural gas development in the Denver-Julesburg Basin, announced key leadership changes with Gregory S. Patton appointed as CEO and Michael J. Shelly as CFO. These appointments aim to support the company's next growth phase, optimize capital structure, and enhance …

KUSTOM ENTERTAINMENT, INC. ANNOUNCES BINDING AGREEMENT FOR THE DIVESTITURE OF ITS VIDEO SOLUTIONS SEGMENT TO FULLY COMPLETE LIVE ENTERTAINMENT PIVOT

KUSTOM ENTERTAINMENT, INC. ANNOUNCES BINDING AGREEMENT FOR THE DIVESTITURE OF ITS VIDEO SOLUTIONS SEGMENT TO FULLY COMPLETE LIVE ENTERTAINMENT PIVOT

Kustom Entertainment, Inc. announces a binding agreement to divest its video solutions segment to Cycurion, Inc. The transaction includes $5.5 million plus 2 million warrants, enabling Kustom to focus on its growing live event production and ticketing business. This aligns with its recent rebranding and partnership with Gilley's Park City, position…

Vivani Medical Receives Regulatory Approval for the Initiation of SLIM-1, a Phase 1 Clinical Trial of NPM-139 Semaglutide Implant in Obesity and Chronic Weight Management

Vivani Medical Receives Regulatory Approval for the Initiation of SLIM-1, a Phase 1 Clinical Trial of NPM-139 Semaglutide Implant in Obesity and Chronic Weight Management

Vivani Medical has obtained regulatory approval from an Australian human research ethics committee to initiate its Phase 1 clinical trial, SLIM-1, testing the NPM-139 semaglutide implant designed for obesity and chronic weight management. This implant aims to improve medication adherence by providing a steady drug delivery over an extended period. …

VCI Global Strengthens Capital Alignment Following Premium Warrant Conversion by Institutional Investor

VCI Global Strengthens Capital Alignment Following Premium Warrant Conversion by Institutional Investor

VCI Global Limited announces that Esousa Group Holdings LLC, a New York-based institutional investor, converted warrants into 880,000 shares of common stock at a 24.9% premium to the previous closing price. This conversion underscores institutional confidence in VCI Global's AI-native platform strategy and strengthens the company's equity capital s…

NuCube Energy to Become a Publicly Listed Company Through Business Combination with Launch Two Acquisition Corp.

NuCube Energy to Become a Publicly Listed Company Through Business Combination with Launch Two Acquisition Corp.

NuCube Energy, an advanced nuclear technology firm developing solid-state microreactors, has agreed to a business combination with Launch Two Acquisition Corp. (NASDAQ: LPBB), bringing NuCube to the public markets with an estimated valuation of $500 million pre-money. NuCube's NuSun™ microreactor technology delivers firm carbon-free power and high-…

Digital Currency X Technology Enters Into Securities Purchase Agreement for a Private Placement of US$700 Million of Units, Payable in U.S. Dollars or Digital Assets, to Advance Its Digital Asset Treasury Strategy

Digital Currency X Technology Enters Into Securities Purchase Agreement for a Private Placement of US$700 Million of Units, Payable in U.S. Dollars or Digital Assets, to Advance Its Digital Asset Treasury Strategy

Digital Currency X Technology Inc. announced a $700 million private placement of units payable in U.S. dollars or digital assets, marking a strategic shift from electric vehicle manufacturing to focus on digital asset treasury management and AI cloud computing services. The financing structure aligns with its digital asset holdings, allowing direct…

Atea Pharmaceuticals Completes Patient Enrollment in Phase 3 C-FORWARD Trial Evaluating Bemnifosbuvir and Ruzasvir for Treatment of Hepatitis C Virus

Atea Pharmaceuticals Completes Patient Enrollment in Phase 3 C-FORWARD Trial Evaluating Bemnifosbuvir and Ruzasvir for Treatment of Hepatitis C Virus

Atea Pharmaceuticals has completed patient enrollment in its Phase 3 C-FORWARD trial evaluating the bemnifosbuvir and ruzasvir combination for hepatitis C treatment outside North America. This milestone advances Atea's global clinical program alongside the ongoing North American C-BEYOND trial, with topline results expected around year-end 2026, po…

Kymera Therapeutics Completes Enrollment in the Phase 2b BROADEN2 Trial of KT-621 in Atopic Dermatitis with Topline Data by Year-end 2026

Kymera Therapeutics Completes Enrollment in the Phase 2b BROADEN2 Trial of KT-621 in Atopic Dermatitis with Topline Data by Year-end 2026

Kymera Therapeutics announced early completion of enrollment in its Phase 2b BROADEN2 clinical trial for KT-621, an oral STAT6 degrader targeting moderate to severe atopic dermatitis. This accelerated enrollment allows for topline data readout by year-end 2026, six months ahead of schedule, and plans to initiate Phase 3 trials by mid-2027. KT-621 i…

Baker Hughes to Deliver Subsea Production Systems to Support Azule Energy’s Greater PAJ Development

Baker Hughes to Deliver Subsea Production Systems to Support Azule Energy’s Greater PAJ Development

Baker Hughes has been awarded a contract by Azule Energy to supply advanced subsea production systems, including deepwater horizontal tree systems and control modules, to support efficient oil production in Angola's ultra-deepwater Greater PAJ development. The company will leverage its local Angolan facilities and supply chain to optimize installat…

Satellos to Present Clinical Program Updates at ICNMD 2026

Satellos to Present Clinical Program Updates at ICNMD 2026

Satellos Bioscience Inc. announced new data from its SAT-3247 clinical development program will be featured at the 19th International Congress on Neuromuscular Diseases (ICNMD). The data includes six-month follow-up results from Phase 1b participants and ongoing Phase 2 trial updates. SAT-3247 is an investigational oral therapy aimed at regeneratin…

Initial Lightbridge Fuel™ Material Samples Removed from Idaho National Laboratory’s Advanced Test Reactor

Initial Lightbridge Fuel™ Material Samples Removed from Idaho National Laboratory’s Advanced Test Reactor

Lightbridge Corporation announced the successful removal of the first batch of its fuel material samples from irradiation testing at INL's Advanced Test Reactor. The samples will now undergo post-irradiation examination, providing critical data to support Lightbridge's nuclear fuel performance modeling, regulatory licensing, and commercial deployme…

Winnebago Industries Reports Third Quarter Fiscal 2026 Results

Winnebago Industries Reports Third Quarter Fiscal 2026 Results

Winnebago Industries announced its third quarter fiscal 2026 results with net revenues of $698.7 million, down 9.9% year-over-year driven by lower unit volumes, despite growth in the Motorhome RV segment. Adjusted EPS declined to $0.66 from $0.81 the prior year, reflecting industry headwinds including elevated fuel costs and weak consumer confidenc…

INmune Bio Inc. Achieves MHRA Approval of PIP for CORDStrom™

INmune Bio Inc. Achieves MHRA Approval of PIP for CORDStrom™

INmune Bio Inc. announced that the UK Medicines & Healthcare products Regulatory Agency (MHRA) approved the Pediatric Investigation Plan (PIP) for Ebstrocel™, part of the CORDStrom™ platform, targeting Recessive Dystrophic Epidermolysis Bullosa (RDEB). This regulatory milestone accelerates the path toward Marketing Authorization in the UK, aligning…

Montauk Brewing Kicks Off Summer with 14th Anniversary Celebration, Limited Brew Barn Release and Beach Cleanup

Montauk Brewing Kicks Off Summer with 14th Anniversary Celebration, Limited Brew Barn Release and Beach Cleanup

Montauk Brewing Co., a craft beer brand under Tilray Brands, Inc., marks its 14th anniversary with a special celebration at its Brew Barn in Montauk, NY. Events include the release of a limited Jalapeño Watermelon Ale, a community beach cleanup, a surfboard raffle benefiting the Surfrider Foundation, local food offerings, and live summer soccer cov…

Seres Therapeutics to Host Webcast on July 8, 2026, to Discuss Results of Investigator-Sponsored Trial of Seres’ SER-155 in Immune Checkpoint Inhibitor-Related Enterocolitis

Seres Therapeutics to Host Webcast on July 8, 2026, to Discuss Results of Investigator-Sponsored Trial of Seres’ SER-155 in Immune Checkpoint Inhibitor-Related Enterocolitis

Seres Therapeutics announced an upcoming webcast to present top-line data from an investigator-sponsored trial evaluating their live biotherapeutic SER-155 for immune checkpoint inhibitor-related enterocolitis (irEC), a severe side effect of cancer immunotherapy. The trial, conducted at Memorial Sloan Kettering Cancer Center, aims to show SER-155's…

Highlander Silver: Comprehensive Geophysical Program Maps Extensive System Concealed by Shallow Cover at Corani

Highlander Silver: Comprehensive Geophysical Program Maps Extensive System Concealed by Shallow Cover at Corani

Highlander Silver Corp. reported results from a detailed geophysical program at its Corani Silver Project, revealing a significantly larger mineral system concealed beneath shallow cover. The company identified several high-priority exploration targets and has commenced the first drilling program in over a decade, with initial assays expected soon.…

GDS Concludes Successful 2026 Annual General Meeting with All Resolutions Passed, Including Election and Re-election of Directors

GDS Concludes Successful 2026 Annual General Meeting with All Resolutions Passed, Including Election and Re-election of Directors

GDS Holdings Limited held its 2026 Annual General Meeting where all shareholder resolutions were approved, including the re-election and election of directors, extension of the equity incentive plan, appointment of auditors, and authorization to issue new shares up to 30% of existing share capital. Leadership changes included the departure of long-…